Cargando…
Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018
Cardiovascular drug research and development (R&D) has been in active state and continuously attracts attention from the pharmaceutical industry. However, only one individual drug can eventually reach the market from about the 10,000 compounds tested. It would be useful to learn from these failu...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769515/ https://www.ncbi.nlm.nih.gov/pubmed/31547243 http://dx.doi.org/10.3390/ijms20184513 |